M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw

Slides:

Advertisements

Similar presentations

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies Don B. Sanders, Huichuan J. Lai,

Advertisements

Cheryl Cameron, Mark W. Lodes, William M. Gershan

The prevalence of “risky behaviour” in adults with cystic fibrosis

Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care delivery J. Abbott, J.S. Elborn, A.M. Georgiopoulos,

P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham

Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis H.J.

R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J

GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis Paul M. Beringer, Levita Hidayat, Anna Heed, Ling.

Abaigeal D. Jackson, Christopher H. Goss Journal of Cystic Fibrosis

How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF? Sarah P. Cohen, David M. Orenstein

Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H

Katarine Egressy, Michaelene Jansen, Keith C. Meyer

Megan R. Nelson, Craig R. Adamski, Audrey Tluczek

A review of renal disease in cystic fibrosis

Urinary incontinence in 9��16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group W.J. Browne, C.J. Wood, M.

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study Doug L. Forrester, Alan J. Knox,

Laura Viviani, Baroukh M. Assael, Eitan Kerem

Cirrhosis and other liver disease in cystic fibrosis

Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin

The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited Abaigeal D. Jackson, Leslie Daly,

Controlled clinical trials in cystic fibrosis — are we doing better?

Natalie Soulsby, Hugh Greville, Kingsley Coulthard, Chris Doecke

Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar

D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

Influence of digital clubbing on oxygen saturation measurements by pulse-oximetry in cystic fibrosis patients Filip Van Ginderdeuren, Karlien Van Cauwelaert,

Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients J.L. Fothergill,

Vitamin A and lung function in CF

Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis

A.H. Gifford Journal of Cystic Fibrosis

M. Wouthuyzen-Bakker, F.A.J.A. Bodewes, H.J. Verkade

Demographics of glucose metabolism in cystic fibrosis

Agreement of bioelectric impedance analysis and dual-energy X-ray absorptiometry for body composition evaluation in adults with cystic fibrosis S. Ziai,

Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C

François Vermeulen, Marijke Proesmans, Mieke Boon, Kris De Boeck

Natalie Soulsby, Hugh Greville, Kingsley Coulthard, Chris Doecke

Elisabeth P. Dellon, Elaine Chen, Jessica Goggin, Karen Homa, Bruce C

Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India Shivaram S. Shastri, Madhulika Kabra, Sushil.

Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor Meredith C. Fidler, Jack Beusmans, Paul Panorchan,

E. Tschiedel, H. Grasemann, F. Ratjen Journal of Cystic Fibrosis

Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?

Ultrasound and magnetic resonance imaging assessment of joint disease in symptomatic patients with cystic fibrosis arthropathy G. Fitch, K. Williams,

Nasal polyposis in lung transplant recipients with cystic fibrosis

Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients E.B. Wilms, D.J. Touw, H.G.M. Heijerman

Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis Geraint B. Rogers, Lucas R. Hoffman,

Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic Amanda L. Griffiths, Danielle F. Wurzel,

Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention H. White, K. Pollard, C. Etherington, I. Clifton,

Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire Joän M. Patterson, Melanie Wall, Jerica.

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies Don B. Sanders, Huichuan J. Lai,

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid

D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation C. Etherington,

CFTR modulators and pregnancy: Our work has only just begun

‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis

Beta-lactam allergy in adults with cystic fibrosis

Cheryl Cameron, Mark W. Lodes, William M. Gershan

Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis

Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz Journal of Cystic Fibrosis

Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub

David Adeboyeku, Sandra Scott, Margaret E. Hodson

Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?

Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L

Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population Elaine.

Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis D.J. Touw, A.J. Knox,

Absence of a gender gap in survival

Cystic fibrosis and pregnancy in the modern era: A case control study

Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening Fiona Cunningham, Sharon Lewis, Lisette.

Presentation transcript:

Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw Journal of Cystic Fibrosis Volume 6, Issue 1, Pages 41-47 (January 2007) DOI: 10.1016/j.jcf.2006.05.004 Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 (a) mCCl and eCCl correlation derived from the Cockroft–Gault formula in CF patients (r=0.69, P<0.001; mean bias 9.7 ml/min). (b) mCCl and eCCl correlation derived from the Cockroft–Gault formula in non-CF controls (r=0.85, P<0.001; mean bias 3.4 ml/min). (c) mCCl and eCCl correlation derived from aMDRD in CF patients (r=0.56, p<0.001; mean bias 4.9 ml/min). (d) mCCl and eCCl correlation derived from aMDRD in non-CF controls (r=0.88, P<0.001; mean bias 1.4 ml/min). Journal of Cystic Fibrosis 2007 6, 41-47DOI: (10.1016/j.jcf.2006.05.004) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 Bland and Altman Plots comparing mCCl with CGF and aMDRD in CF patients. Journal of Cystic Fibrosis 2007 6, 41-47DOI: (10.1016/j.jcf.2006.05.004) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 Percentage of eCCl results falling within 10%, 20% and 33% of mCCl in CF patients and non-CF controls. CGF and aMDRD shown. Journal of Cystic Fibrosis 2007 6, 41-47DOI: (10.1016/j.jcf.2006.05.004) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions